You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

fulvestrant

Showing 26 - 50 of 254
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Ovarian Cancer, Serous Ovarian Cancer Trial in Pittsburgh (Regorafenib, Fulvestrant)

Not yet recruiting
  • Ovarian Cancer
  • Serous Ovarian Cancer
  • Pittsburgh, Pennsylvania
    University of Pittsburgh Cancer Institute
Apr 17, 2022

Breast Cancer Trial in Aurora, New York, Germantown (Enzalutamide, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +2 more
Feb 22, 2022

Breast Tumors Trial in China (Alpelisib, Fulvestrant, Placebo)

Recruiting
  • Breast Neoplasms
  • Hefei, Anhui, China
  • +31 more
Dec 19, 2022

Breast Cancer Trial in United States (Neratinib, Fulvestrant)

Active, not recruiting
  • Breast Cancer
  • Indianapolis, Indiana
  • +5 more
Mar 2, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Hormone Receptor-Positive Breast Carcinoma, Metastatic Breast Carcinoma Trial in United

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +4 more
  • Birmingham, Alabama
  • +12 more
Nov 9, 2022

Advanced Breast Cancer Trial in Changsha (BEBT-209 capsules, Letrozole tablets, Fulvestrant)

Active, not recruiting
  • Advanced Breast Cancer
  • BEBT-209 capsules
  • +2 more
  • Changsha, Hunan, China
  • +1 more
Sep 14, 2023

Tumor, Breast, Congenital, Familial and Genetic Disorders Trial in Netherlands (Alpelisib 150 MG Oral Tablet [Piqray],

Recruiting
  • Neoplasm, Breast
  • Congenital, Familial and Genetic Disorders
  • Alpelisib 150 MG Oral Tablet [Piqray]
  • Fulvestrant
  • Almelo, Netherlands
  • +15 more
Jan 11, 2023

Advanced Breast Cancer, Metastatic Breast Cancer, Breast Cancer Trial in United States (NUV-422, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • +7 more
  • Anaheim, California
  • +4 more
Apr 6, 2022

Fulvestrant in Postmenopausal Advanced Breast Cancer HR+, HER2-

Recruiting
  • Breast Neoplasm Female
  • Fulvestrant
  • Valledupar, Cesar, Colombia
    SOHEC
Nov 30, 2021

Breast Cancer Trial in Singapore (Lenvatinib + Letrozole, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • Lenvatinib + Letrozole
  • Fulvestrant
  • Singapore, Singapore
    Nationa University Hospital
Jan 4, 2022

Carcinoma, Ductal, Breast, Breast Cancer, Breast Tumor Trial in Worldwide (G1T38, Fulvestrant)

Active, not recruiting
  • Carcinoma, Ductal, Breast
  • +2 more
  • Sofia, Bulgaria
  • +7 more
Aug 1, 2022

Estrogen Receptor Positive Breast Cancer Trial in United Kingdom (AZD5363, Placebo, Fulvestrant)

Active, not recruiting
  • Estrogen Receptor Positive Breast Cancer
  • Manchester, Greater Manchester, United Kingdom
  • +20 more
Aug 5, 2022

Anatomic Stage IV Breast Cancer AJCC v8, Metastatic Breast Carcinoma, Prognostic Stage IV Breast Cancer AJCC v8 Trial in Houston

Recruiting
  • Anatomic Stage IV Breast Cancer AJCC v8
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Oct 25, 2022

Breast Cancer, Advanced Breast Cancer, Metastatic Breast Cancer Trial (OP-1250, Fulvestrant, Anastrozole)

Not yet recruiting
  • Breast Cancer
  • +4 more
  • (no location specified)
Aug 31, 2023

Estrogen Receptor-positive Breast Cancer, HER2-positive Breast Cancer Trial in Shanghai (Palbociclib, trastuzumab, pyrotinib)

Recruiting
  • Estrogen Receptor-positive Breast Cancer
  • HER2-positive Breast Cancer
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Hospital
Sep 29, 2021

Metastatic Breast Cancer, Hormone Receptor Positive Trial in United States (Palbociclib, Tamoxifen, Fulvestrant)

Completed
Has Results
  • Metastatic Breast Cancer
  • Hormone Receptor Positive
  • San Francisco, California
  • +8 more
Feb 16, 2022

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

Advanced Breast Cancer Trial in Shenyang (Chidamide, Fulvestrant)

Recruiting
  • Advanced Breast Cancer
  • Shenyang, Liaoning, China
    Liangning Tumor Hospital &Institute
Sep 8, 2021

Metastatic Breast Cancer, Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Hormone Receptor Positive Breast Cancer

Recruiting
  • Metastatic Breast Cancer
  • +2 more
  • Washington, District of Columbia
    Lombardi Comprehensive Cancer Center
Jan 17, 2022

Advanced Breast Cancer Trial in Lebanon (Fulvestrant, Neratinib, Alpelisib)

Not yet recruiting
  • Advanced Breast Cancer
  • Fulvestrant
  • +4 more
  • Lebanon, New Hampshire
    Dartmouth Hitchcock Medical Center
Jun 28, 2023

Metastatic Breast Cancer Trial in United States (Palbociclib, Fulvestrant)

Recruiting
  • Metastatic Breast Cancer
  • Washington, District of Columbia
  • +4 more
Jan 10, 2022

Breast Cancer Trial (Tucidinostat, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 7, 2021

Breast Cancer, Gynecologic Cancer, HNSCC Trial in Boston (STX-478, Fulvestrant)

Recruiting
  • Breast Cancer
  • +3 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Mar 13, 2023

Breast Cancer Trial (RP-6306, Gemcitabine, Observation)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Jan 26, 2023

Metastatic Breast Cancer Trial in Pittsburgh (Fulvestrant, Tamoxifen, Palbociclib)

Active, not recruiting
  • Metastatic Breast Cancer
  • Fulvestrant
  • +2 more
  • Pittsburgh, Pennsylvania
    Magee-Womens Hospital UPMC
Jul 22, 2021